Sean P. David, M.D., D.Phil.

Publications

• Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers.
  Strong, D. R., David, S. P., Johnstone, E. C., Aveyard, P., Murphy, M. F., & Munafò, M. R. (2015). Differential Efficacy of Nicotine Replacement Among Overweight and Obese Women Smokers. Nicotine & tobacco research , 17(7), 855-861.
• Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students.
  Hayes, R. B., Geller, A. C., Crawford, S. L., Jolicoeur, D. G., Churchill, L. C., & Ockene, J. K. (2015). Medical school curriculum characteristics associated with intentions and frequency of tobacco dependence treatment among 3rd year U.S. medical students. Preventive medicine, 72, 56-63.
• Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative.
  Henderson, M. T., Kubo, J. T., Desai, M., David, S. P., Tindle, H., & Tang, J. Y. (2015). Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative. Journal of the American Academy of Dermatology, 72(1), 190-191.e3.
• Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial. Ockene, J. K., Hayes, R. B., Churchill, L. C., Crawford, S. L., Jolicoeur, D. G., & Geller, A. C. (2015). Teaching Medical Students to Help Patients Quit Smoking: Outcomes of a 10-School Randomized Controlled Trial. Journal of general internal medicine.
  
• Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable. David, S. P., Johnson, S. G., Berger, A. C., Feero, W. G., Terry, S. F., & Ginsburg, G. S. (2015). Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable. Annals of family medicine, 13(4), 373-80.
  
• Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative Henderson, M. T., Kubo, J. T., Desai, M., David, S. P., Tindle, H., & Tang, J. Y. (2015). Smoking behavior and association of melanoma and nonmelanoma skin cancer in the Women's Health Initiative. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(1), 190-191.
  
• Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Weng, D. Y., Chen, J., Taslim, C., Hsu, P. C., Marian, C., & Shields, P. G. (2015). Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers. Molecular carcinogenesis.
  
• Association of CHRNA5-A3-84 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers Zhu, A. Zx., Zhou, Q., Cox, L. S., David, S. P., Ahluwalia, J. S., & Tyndale, R. F. (2014). Association of CHRNA5-A3-84 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers. CLINICAL PHARMACOLOGY & THERAPEUTICS, 96(2), 256-265.
  
• Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Xu, X., Clark, U. S., David, S. P., Mulligan, R. C., Knopik, V. S., & Sweet, L. H. (2014). Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype. Nicotine & tobacco research , 16(7), 939-947.
  
• Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention Ioannidis, J. Pa., Munafo, M. R., Fusar-Poli, P., Nosek, B. A., & David, S. P. (2014). Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. TRENDS IN COGNITIVE SCIENCES, 18(5), 235-241.
  
• Clinical interpretation and implications of whole-genome sequencing. Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA-the journal of the American Medical Association, 311(10), 1035-1045.
  
• Teaching tobacco dependence treatment and counseling skills during medical school: Rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial. Hayes, R. B., Geller, A., Churchill, L., Jolicoeur, D., Murray, D. M., & Ockene, J. K. (2014). Teaching tobacco dependence treatment and counseling skills during medical school: Rationale and design of the Medical Students helping patients Quit tobacco (MSQuit) group randomized controlled trial. Contemporary clinical trials, 37(2), 284-293.
  
• Commentary on Chen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation? David, S. P. (2014). Commentary on Chen et al. (2014): Another step on the road to clinical utility of pharmacogenetics for smoking cessation?. ADDICTION, 109(1), 138-139.
  
• Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. David, S. P., Strong, D. R., Leventhal, A. M., Lancaster, M. A., McGeary, J. E., & Niaura, R. (2013). Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction , 108(12), 2202-2211.
  
• Tobacco dependence treatment teaching by medical school clerkship preceptors: Survey responses from more than 1000 US medical students Geller, A. C., Hayes, R. B., Leone, F., Churchill, L. C., Leung, K., & Ockene, J. K. (2013). Tobacco dependence treatment teaching by medical school clerkship preceptors: Survey responses from more than 1000 US medical students. PREVENTIVE MEDICINE, 57(2), 81-86.
  
• Potential Reporting Bias in fMRI Studies of the Brain David, S. P., Ware, J. J., Chu, I. M., Loftus, P. D., Fusar-Poli, P., & Ioannidis, J. Pa. (2013). Potential Reporting Bias in fMRI Studies of the Brain. PLOS ONE, 8(7).
  
• Biomarkers for smoking cessation. Bough, K. J., Lerman, C., Rose, J. E., McClernon, F. J., Kenny, P. J., & Amur, S. (2013). Biomarkers for smoking cessation. Clinical pharmacology & therapeutics, 93(6), 526-538.
  
• Communities of Solution: Partnerships for Population Health Griswold, K. S., Lesko, S. E., & Westfall, J. M. (2013). Communities of Solution: Partnerships for Population Health. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 26(3), 232-238.
  
• Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study McClure, J. B., Swan, G. E., St John, J., Fauver, R., Javitz, H. S., & David, S. P. (2013). Pharmacogenetic Smoking Cessation Intervention in a Health Care Setting: A Pilot Feasibility Study. NICOTINE & TOBACCO RESEARCH, 15(2), 518-526.
  
• Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Fusar-Poli, P., Joaquim, R., Marianna, F., Andrea, M., Stefan, B., & David, S. P. (2013). Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Human Brain Mapping.
  
• CHRONIC STRESS & SALIVARY BIOMARKERS Mallick, A., Bergen, A., Nishita, D., Wei, X., Michel, M., & Andrews, J. (2013). CHRONIC STRESS & SALIVARY BIOMARKERS. JOURNAL OF INVESTIGATIVE MEDICINE, 61(1), 141-141.
  
• Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers Liu, T., Tyndale, R. F., David, S. P., Wang, H., Yu, X.-Q., & Chen, W.-Q. (2013). Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers. JOURNAL OF HUMAN HYPERTENSION, 27(1), 24-30.
  
• Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion David, S. P., Strong, D. R., Leventhal, A. M., Lancaster, M. A., McGeary, J. E., & Niaura, R. (2013). Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction, 108(12).
  
• Opioid antagonists for smoking cessation David, S. P., Lancaster, T., Stead, L. F., Evins, A. E., & Prochaska, J. J. (2013). Opioid antagonists for smoking cessation. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (6).
  
• No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Passarelli, M. N., Newcomb, P. A., Makar, K. W., Burnett-Hartman, A. N., Phipps, A. I., & Peters, U. (2013). No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women. Menopause (New York, N.Y.).
  
• PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6 McDonagh, E. M., Wassenaar, C., David, S. P., Tyndale, R. F., Altman, R. B., & Klein, T. E. (2012). PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. PHARMACOGENETICS AND GENOMICS, 22(9), 695-708.
  
• Improving America's health requires community-level solutions: Folsom revisited. Improving America's health requires community-level solutions: Folsom revisited. (2012). Improving America's health requires community-level solutions: Folsom revisited. American family physician, 86(4), 1-2.
  
• Chronic psychosocial stressors and salivary biomarkers in emerging adults Bergen, A. W., Mallick, A., Nishita, D., Wei, X., Michel, M., & Andrews, J. A. (2012). Chronic psychosocial stressors and salivary biomarkers in emerging adults. PSYCHONEUROENDOCRINOLOGY, 37(8), 1158-1170.
  
• Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry-A Meta-Analysis of Chromosome 15q25 Chen, L.-S., Saccone, N. L., Culverhouse, R. C., Bracci, P. M., Chen, C.-H., & Bierut, L. J. (2012). Smoking and Genetic Risk Variation Across Populations of European, Asian, and African American Ancestry-A Meta-Analysis of Chromosome 15q25. GENETIC EPIDEMIOLOGY, 36(4), 340-351.
  
• Genome-wide meta-analyses of smoking behaviors in African Americans David, S. P., Hamidovic, A., Chen, G. K., Bergen, A. W., Wessel, J., & Furberg, H. (2012). Genome-wide meta-analyses of smoking behaviors in African Americans. TRANSLATIONAL PSYCHIATRY, 2.
  
• Communities of Solution: The Folsom Report Revisited Lesko, S., Griswold, K. S., David, S. P., Bazemore, A. W., Duane, M., & Green, L. A. (2012). Communities of Solution: The Folsom Report Revisited. ANNALS OF FAMILY MEDICINE, 10(3), 250-260.
  
• The neuroeconomics of nicotine dependence: A preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers MacKillop, J., Amlung, M. T., Wier, L. M., David, S. P., Ray, L. A., & Sweet, L. H. (2012). The neuroeconomics of nicotine dependence: A preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. PSYCHIATRY RESEARCH-NEUROIMAGING, 202(1), 20-29.
  
• Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers Liu, T., David, S. P., Tyndale, R. F., Wang, H., Yu, X.-Q., & Chen, W.-Q. (2012). Relationship Between Amounts of Daily Cigarette Consumption and Abdominal Obesity Moderated by CYP2A6 Genotypes in Chinese Male Current Smokers. ANNALS OF BEHAVIORAL MEDICINE, 43(2), 253-261.
  
• Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation Leventhal, A. M., David, S. P., Brightman, M., Strong, D., McGeary, J. E., & Niaura, R. (2012). Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. PHARMACOGENOMICS JOURNAL, 12(1), 86-92.
  
• Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women Janes, A. C., Smoller, J. W., David, S. P., Frederick, B. B., Haddad, S., & Kaufman, M. J. (2012). Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent women. DRUG AND ALCOHOL DEPENDENCE, 120(1-3), 7-13.
  
• Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways Liu, T., Chen, W.-Q., David, S. P., Tyndale, R. F., Wang, H., & Ling, W.-H. (2011). Interaction between heavy smoking and CYP2A6 genotypes on type 2 diabetes and its possible pathways. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 165(6), 961-967.
  
• Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence Dewey, F. E., Chen, R., Cordero, S. P., Ormond, K. E., Caleshu, C., & Ashley, E. A. (2011). Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence. PLOS GENETICS, 7(9).
  
• Associations of CYP2A6 genotype with smoking behaviors in southern China Liu, T., David, S. P., Tyndale, R. F., Wang, H., Zhou, Q., & Chen, W.-Q. (2011). Associations of CYP2A6 genotype with smoking behaviors in southern China. ADDICTION, 106(5), 985-994.
  
• Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials David, S. P., Johnstone, E. C., Churchman, M., Aveyard, P., Murphy, M. Fg., & Munafo, M. R. (2011). Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials. NICOTINE & TOBACCO RESEARCH, 13(3), 157-?.
  
• Application of Functional Neuroimaging Methods to Nicotine Dependence. David SP., Sweet L, Cohen R, MacKillop J, Mulligan RC, & Niaura R. (2010). Application of Functional Neuroimaging Methods to Nicotine Dependence. In: Brain Imaging in Behavioral Medicine and Neuropsychology. Edited by Cohen R. Springer, New York, NY, USA. (text book in press)..
  
• Effects of nicotine withdrawal on verbal working memory and associated brain response Sweet, L. H., Mulligan, R. C., Finnerty, C. E., Jerskey, B. A., David, S. P., & Niaura, R. S. (2010). Effects of nicotine withdrawal on verbal working memory and associated brain response. PSYCHIATRY RESEARCH-NEUROIMAGING, 183(1), 69-74.
  
• Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement Uhl, G. R., Drgon, T., Johnson, C., Walther, D., Aveyard, P., & Munafo, M. R. (2010). Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. PHARMACOGENOMICS, 11(3), 357-367.
  
• Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans David, S. P., Mezuk, B., Zandi, P. P., Strong, D., Anthony, J. C., & Eaton, W. W. (2010). Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. NICOTINE & TOBACCO RESEARCH, 12(3), 251-262.
  
• Dopamine Transporters: Chemistry, Biology, and Pharmacology. David SP. (2009). Dopamine Transporters: Chemistry, Biology, and Pharmacology. Clin Pharmacol Ther., 85(1).
  
• Lifestyle Medicine by Gary Egger, Andrew Binns, and Stephen Rossner. David SP. (2009). Lifestyle Medicine by Gary Egger, Andrew Binns, and Stephen Rossner. Am J Lifestyle Med., 3(9).
  
• Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data Munafo, M. R., Timpson, N. J., David, S. P., Ebrahim, S., & Lawlor, D. A. (2009). Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data. NICOTINE & TOBACCO RESEARCH, 11(1), 64-76.
  
• [Smoking cessation]. Koplan, K. E., David, S. P., & Rigotti, N. A. (2008). [Smoking cessation]. Praxis, 97(22), 1185-1186.
  
• Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses David, S. P., Johnstone, E. C., Murphy, M. Fg., Aveyardd, P., Guo, B., & Munafo, M. R. (2008). Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: New data from the Patch in Practice trial and pooled analyses. DRUG AND ALCOHOL DEPENDENCE, 98(1-2), 77-85.
  
• Genetic variation in the dopamine pathway and smoking cessation David, S. P., & Munafo, M. R. (2008). Genetic variation in the dopamine pathway and smoking cessation. PHARMACOGENOMICS, 9(9), 1307-1321.
  
• Molecular genetics of successful smoking cessation - Convergent genome-wide association study results Uhl, G. R., Liu, Q.-R., Drgon, T., Johnson, C., Walther, D., & Rose, E. (2008). Molecular genetics of successful smoking cessation - Convergent genome-wide association study results. ARCHIVES OF GENERAL PSYCHIATRY, 65(6), 683-693.
  
• Smoking cessation in primary care David, S. P., & Munafo, M. R. (2008). Smoking cessation in primary care. BRITISH MEDICAL JOURNAL, 336(7655), 1200-1201.
  
• Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch David, S. P., Munafo, M. R., Murphy, M. Fg., Proctor, M., Walton, R. T., & Johnstone, E. C. (2008). Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. PHARMACOGENOMICS JOURNAL, 8(2), 122-128.
  
• Smoking cessation. Koplan, K. E., David, S. P., & Rigotti, N. A. (2008). Smoking cessation. BMJ (Clinical research ed.), 336(7637), 217-?.
  
• A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation Welton, N. J., Johnstone, E. C., David, S. P., & Munafo, M. R. (2008). A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. NICOTINE & TOBACCO RESEARCH, 10(1), 231-240.
  
• Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: A diffusion tensor imaging study Paul, R. H., Grieve, S. M., Niaura, R., David, S. P., Laidlaw, D. H., & Gordon, E. (2008). Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: A diffusion tensor imaging study. NICOTINE & TOBACCO RESEARCH, 10(1), 137-147.
  
• Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study David, S. P., Munafo, M. R., Johansen-Berg, H., MacKillop, J., Sweet, L. H., & Walton, R. T. (2007). Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. BRAIN IMAGING AND BEHAVIOR, 1(3-4), 43-57.
  
• Successful Latino community partnership program for smoking cessation David, S. P., Smith, M., Lee, C. S., & Sullivan, G. (2007). Successful Latino community partnership program for smoking cessation. AMERICAN JOURNAL OF PUBLIC HEALTH, 97(8), 1348-1349.
  
• Association of COMT Val(108/158) met genotype with smoking cessation in a nicotine replacement therapy randomized trial Johnstone, E. C., Elliot, K. M., David, S. P., Murphy, M. Fg., Walton, R. T., & Munafo, M. R. (2007). Association of COMT Val(108/158) met genotype with smoking cessation in a nicotine replacement therapy randomized trial. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 16(6), 1065-1069.
  
• The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial David, S. P., Munafo, M. R., Murphy, M. Fg., Walton, R. T., & Johnstone, E. C. (2007). The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: Follow-up of a randomized controlled trial. NICOTINE & TOBACCO RESEARCH, 9(2), 225-231.
  
• Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation David, S. P., Brown, R. A., Papandonatos, G. D., Kahler, C. W., Lloyd-Richardson, E. E., & Niaura, R. (2007). Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. NICOTINE & TOBACCO RESEARCH, 9(8), 821-833.
  
• Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. David, S. P., Munafò, M. R., Johansen-Berg, H., Mackillop, J., Sweet, L. H., & Walton, R. T. (2007). Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study. Brain imaging and behavior, 1(3-4), 43-57.
  
• Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials David, S. P., Strong, D. R., Munafo, M. R., Brown, R. A., Lloyd-Richardson, E. E., & Niaura, R. (2007). Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials. NICOTINE & TOBACCO RESEARCH, 9(12), 1251-1257.
  
• Building a successful research enterprise in family medicine: the Brown experience. David, S. P., Eaton, C. B., Culpepper, L., Goldman, R. E., Lavallee, L. K., & Simmons, E. M. (2006). Building a successful research enterprise in family medicine: the Brown experience. Medicine and health, Rhode Island, 89(8), 281-284.
  
• Fellowship training in family medicine at Brown: adding depth to breadth. Long, R., David, S. P., Monroe, A., & Shaw, J. (2006). Fellowship training in family medicine at Brown: adding depth to breadth. Medicine and health, Rhode Island, 89(8), 274-275.
  
• Studies of Genetic Influences on Nicotine Dependence Utilising Functional Neuroimaging. David SP. (2006). Studies of Genetic Influences on Nicotine Dependence Utilising Functional Neuroimaging. Doctoral thesis: University of Oxford, Bodleian Library, Oxford, UK..
  
• Opioid antagonists for smoking cessation David, S., Lancaster, T., Stead, L. F., & Evins, A. E. (2006). Opioid antagonists for smoking cessation. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (4).
  
• The Pharmacogenetics of Nicotine Addiction and Smoking Cessation. David SP., Munaf_ M, & Walton RT. (2006). The Pharmacogenetics of Nicotine Addiction and Smoking Cessation. Chapter 21 in: Pharmacogenomics and Proteomics: Enabling the Practice of Personalized Medicine. Edited by Wong SHY, Linder MW, Valdes, Jr. R. AACC Press, Washington, DC..
  
• Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: A functional magnetic resonance imaging study David, S. P., Munafo, M. R., Johansen-Berg, H., Smith, S. M., Rogers, R. D., & Walton, R. T. (2005). Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: A functional magnetic resonance imaging study. BIOLOGICAL PSYCHIATRY, 58(6), 488-494.
  
• A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans David, S. P., Murthy, N. V., Rabiner, E. A., Munafo, M. R., Johnstone, E. C., & Grasby, P. M. (2005). A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. JOURNAL OF NEUROSCIENCE, 25(10), 2586-2590.
  
• Does providing hereditary breast cancer risk assessment support to practicing physicians decrease the likelihood of them discussing such risk with their patients? Gramling, R., Duffy, C., & David, S. (2004). Does providing hereditary breast cancer risk assessment support to practicing physicians decrease the likelihood of them discussing such risk with their patients?. GENETICS IN MEDICINE, 6(6), 542-542.
  
• Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. David, S. P., Eaton, C. B., Taylor, J. S., Stamp, M. J., Cyr, M., & Walton, R. (2004). Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. Medicine and health, Rhode Island, 87(11), 336-340.
  
• Investigating subgroups in smoking cessation treatment response: Response to Perkins Munafo, M. R., Bradburn, M., Bowes, L., & David, S. (2004). Investigating subgroups in smoking cessation treatment response: Response to Perkins. NICOTINE & TOBACCO RESEARCH, 6(5), 865-867.
  
• Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis Munafo, M., Bradburn, M., Bowes, L., & David, S. (2004). Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. NICOTINE & TOBACCO RESEARCH, 6(5), 769-776.
  
• Pharmacogenetics David, S. P. (2004). Pharmacogenetics. PRIMARY CARE, 31(3), 543-?.
  
• Evaluation of an educational intervention for medical students to promote competency in social and community determinants of health. David SP., Taylor JS, Monroe A, Goldman R, Green AR, & Sagaties D. (2004). Evaluation of an educational intervention for medical students to promote competency in social and community determinants of health. ABSAME, 10(2).
  
• Investigating subgroups in smoking cessation treatment response: Response to Perkins. Munaf_ M, Bradburn M, Bowes L, & David S. (2004). Investigating subgroups in smoking cessation treatment response: Response to Perkins. Nicotine Tob Res, 6(5).
  
• Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? David, S. P., Niaura, R., Papandonatos, G. D., Shadel, W. G., Burkholder, G. J., & Walton, R. T. (2003). Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?. NICOTINE & TOBACCO RESEARCH, 5(6), 935-942.
  
• Should we offer routine breast cancer screening with mammography? David, S. P. (2003). Should we offer routine breast cancer screening with mammography?. AMERICAN FAMILY PHYSICIAN, 68(2), 260-262.
  
• Genetic susceptibility to breast cancer: Teaching points Gramling, R., & David, S. (2003). Genetic susceptibility to breast cancer: Teaching points. FAMILY MEDICINE, 35(7), 466-468.
  
• Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels" David, S. P., & Eaton, C. B. (2003). Comment on "The public health implications of smoking-induced decreased serum and red blood cell folate levels". NICOTINE & TOBACCO RESEARCH, 5(3), 397-399.
  
• Are family physicians willing to use pharmacogenetics for smoking cessation therapy? Stamp, M. J., & David, S. P. (2003). Are family physicians willing to use pharmacogenetics for smoking cessation therapy?. FAMILY MEDICINE, 35(2), 83-83.
  
• Should we prescribe antibiotics for acute conjunctivitis? David, S. P. (2002). Should we prescribe antibiotics for acute conjunctivitis?. American family physician, 66(9), 1649-1650.
  
• Should we use multiple risk factor interventions for the primary prevention of coronary heart disease? David, S. P. (2002). Should we use multiple risk factor interventions for the primary prevention of coronary heart disease?. AMERICAN FAMILY PHYSICIAN, 66(2), 245-246.
  
• No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation David, S. P., Johnstone, E., Griffiths, S. E., Murphy, M., Yudkin, P., & Walton, R. (2002). No association between functional catechol O-methyl transferase 1947A > G polymorphism and smoking initiation, persistent smoking or smoking cessation. PHARMACOGENETICS, 12(3), 265-268.
  
• Should we recommend nicotine replacement therapy? David, S. P. (2001). Should we recommend nicotine replacement therapy?. AMERICAN FAMILY PHYSICIAN, 63(11), 2245-2247.
  
• A civic role for physicians in the promotion of global tobacco control David, S. P. (2001). A civic role for physicians in the promotion of global tobacco control. FAMILY PRACTICE, 18(1), 107-107.
  
• Social marketing: Application to medical education David, S. P., & Greer, D. S. (2001). Social marketing: Application to medical education. ANNALS OF INTERNAL MEDICINE, 134(2), 125-127.
  
• Opioid antagonists for smoking cessation. David, S., Lancaster, T., & Stead, L. F. (2001). Opioid antagonists for smoking cessation. Cochrane database of systematic reviews , (3), CD003086-?.
  
• Smoking cessation for the primary care physician. David SP. (2001). Smoking cessation for the primary care physician. Prim Care Rep., 7(24).
  
• International tobacco control: A focus group study of US anti-tobacco activists David, S., DeJong, W., & Resnick, N. (2001). International tobacco control: A focus group study of US anti-tobacco activists. JOURNAL OF PUBLIC HEALTH POLICY, 22(4), 415-428.
  
• Media advocacy for the office-based teacher of family medicine David, S. P. (2001). Media advocacy for the office-based teacher of family medicine. FAMILY MEDICINE, 33(1), 16-18.
  
• Reflections from a rotation in Cambridge, England David, S. P. (2000). Reflections from a rotation in Cambridge, England. FAMILY MEDICINE, 32(5), 310-312.
  
• The Transatlantic Conference on Tobacco (TACT): a model for international tobacco policy activism. David, S. P. (1998). The Transatlantic Conference on Tobacco (TACT): a model for international tobacco policy activism. Journal of cancer education , 13(4), 253-254.